To validate the biological significance of in vitro results, we also investigated whether neutrophils isolated from patients with active SLE, hence displaying the “IFN-signature”, produce altered levels of IL-6 in response to activation via TLR8. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.